ID.1
Item
subjects chronically infected with hcv genotype 1 or 4
boolean
ID.2
Item
hcv rna viral load of ≥ 100,000 iu/ml
boolean
ID.3
Item
no previous exposure to interferon, pegifnα, or rbv
boolean
ID.4
Item
results of a liver biopsy demonstrating absence of cirrhosis obtained ≤ 24 months prior to randomization. compensated cirrhotics with hcv genotype 1 infection are eligible, but will be capped at 10% of the randomized study population (biopsy can be from any time period prior to randomization)
boolean
ID.5
Item
ultrasound, ct scan, or mri results 12 months prior to randomization that do not demonstrate evidence of hepatocellular carcinoma
boolean
ID.6
Item
body mass index (bmi) of 18 to 35 kg/m²
boolean
ID.7
Item
positive for hepatitis b or hiv-1/hiv-2 antibody at screening
boolean
ID.8
Item
evidence of a medical condition associated with chronic liver disease other than hcv
boolean
ID.9
Item
evidence of decompensated cirrhosis based on radiologic criteria or biopsy
boolean